Cite
MLA Citation
Marie-Anne Debily et al.. “PDTM-36. WHOLE EXOME SEQUENCING (WES) OF DIPG PATIENTS FROM THE BIOMEDE TRIAL REVEALS NEW PROGNOSTIC SUBGROUPS WITH SPECIFIC ONCOGENIC PROGRAMMES.” Neuro-oncology, vol. 21, n.d., p. vi195. http://access.bl.uk/ark:/81055/vdc_100101669129.0x000031